Search Results for "Proxeon Biosystems Odense"
Original Source: Proxeon Biosystems A/S
Proxeon was incorporated in 2002 under the laws of Denmark and has become a leading provider of proteomics technology as was its predecessor, Protana (which was acquired by MDS Proteomics Inc in 2000).The core competencies of Proxeon are in the areas of mass spectrometry, protein analysis, and the design of hardware and software for proteome analysis. These strengths position Proxeon as a uniquely capable developer of proteomics technology, leading to products that are provided globally to leading research...
Matching Channels
None
Matching News
AyoxxA Biosystems closes 2.6M Euro Series A financing round
AyoxxA Biosystems, an international biotechnology company, today announces it has closed a 2.6 million Euro Series A financing round. The round was led by Wellington Partners Venture Capital and inclu...
Tecan and TAP Biosystems to automate RAFT™ 3D cell culturing on the Freedom EVO®
Tecan and TAP Biosystems have announced a co-marketing agreement...
Rapid Micro Biosystems Announces ISO 9001:2008 Certification
BEDFORD, MA -- (Marketwired) -- 04/16/13 -- Rapid Micro Biosystems, the provider of rapid, automated, non-destructive detection and enumeration technologies in microbiology, today announced it has be...
Leica Biosystems Launches the EXPERIENCELAB Tour
Leica Biosystems announced the launch of the EXPERIENCELAB tour, a mobile demonstration lab that showcases Leica's full line of anatomical pathology solutions. Customers will be able to visit the EXPE...
Aushon BioSystems ernennt Bill Williams zum neuen Vice President of Sales
BILLERICA, Massachusetts, 1. Nov. 2012 /- Aushon BioSystems gab heute bekannt, dass Bill Williams, Ph.D. mit sofortiger Wirkung zum Vice President of Sales ernannt wurde. Dr. Williams untersteht damit...
T2 Biosystems' Candida diagnostic test wins US patent
US-based T2 Biosystems has received a patent from US Patent and Trademark Office covering its T2Candida test.
Aushon BioSystems names Martin Verhoef as CEO
Aushon BioSystems, a provider of multiplex immunoassay products, has appointed Martin Verhoef as the company's new chief executive officer (CEO).
T2 Biosystems pulls in $40M in Series E funding round
A Series E funding round led by Goldman Sachs has brought in $40 million for T2 Biosystems. -More-
